chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Psoriasis
Clinical narrative: Exacerbation of psoriasis; This is a spontaneous report received from a Physician.  A patient (age and gender not provided) received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "psoriasis" (ongoing). The patient's concomitant medications were not reported. The following information was reported: PSORIASIS (non-serious), outcome "unknown", described as "Exacerbation of psoriasis". Batch/lot number is not provided, and it cannot be obtained.
Sex: U
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired dose of Pentacel that was administered to a patient today, with no adverse event; Initial information received on 22-Feb-2024 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient to whom expired dose of pentacel that was administered today, with no adverse event.  It is unknown if the patient had any medical history, concomitant disease or risk factor. The patient's past medical treatment(s), vaccination(s) and family history were not provided.   On 22-Feb-2024, the patient received suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE, Suspension for injection lot UJ841AA, expiry date- 19-Feb-2024 via unknown route in unknown administration site for immunization (dose and strength unknown) with no adverse event (expired product administered) (latency same day).  It is unknown if there were lab data/results available  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.0
Sex: M
Vaccine: HIBV
Symptoms: No adverse event, Product preparation issue
Clinical narrative: an inappropriate use due to patient was administered with only the diluent with no reported adverse event; Initial information received on 22-Feb-2024 regarding an unsolicited valid  non-serious case received from a Nurse.  This case is linked to cases 2024SA063592, 2024SA063693 and 2024SA063603.  This case involves a 1 years old male patient who was administered with only the diluent and no active ingredient of HIB (PRP/T) Vaccine [ACT-HIB] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date in August 2023, the patient had received 0.5 ml, with only the diluent and no active ingredient of suspect HIB (PRP/T) Vaccine (Powder and solvent for solution for injection) (lot UJ835AA; expiration date: 22-Feb-2024; strength, route and administration site not reported) for Immunization with no reported adverse event (product preparation error) (latency: same day).  It was reported that "they had one box with 5 doses of ACTHIB vaccine, and now she has two vaccines left from that box and one vaccine in the box doesn't have a diluent to match it. So, she suspects that of the 4 doses given, one was given with only the diluent. They are not sure which of the patients got only a diluent."   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: TYP
Symptoms: No adverse event, Syringe issue
Clinical narrative: during the injection medication leaked onto the patient/some of the vaccine spilled out of the syringe, with no reported adverse event; during the injection medication leaked onto the patient/some of the vaccine spilled out of the syringe, with no reported adverse event; during the injection medication leaked onto the patient/they were unsure if the patient received a full dose,with no reported adverse event; Initial information received on 23-Feb-2024 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient for whom during the injection medication leaked onto the patient/some of the vaccine spilled out of the syringe, with no reported adverse event, and they were unsure if the patient received a full dose, with no reported adverse event while receiving Typhoid Vi Polysaccharide Vaccine [Typhim VI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of 0.4 ml of suspect Typhoid Vi Polysaccharide Vaccine Solution for injection (lot number, strength, expiry date- not reported) via unknown route in unknown administration site for Immunization. Information on the batch number was requested.  On an unknown date, during the injection medication leaked onto the patient/some of the vaccine spilled out of the syringe, with no reported adverse event (accidental exposure to product) (exposure via skin contact) and they were unsure if the patient received a full dose, with no reported adverse event (incorrect dose administered) (latency- same day) following the administration of Typhoid Vi Polysaccharide Vaccine.  Reportedly, The physician believes that the patient received only 0.4 mL. She mentioned that she wasn't in the room during the injection, and there was no actual PTC witnessed. However, the medical assistant mentioned that the needle was a bit bent. The physician wants to know if they can administer the injection again and if they could be approved for a replacement.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.33
Sex: M
Vaccine: HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: inappropriate use due to inadvertently giving an expired dose of vaccine to a patient with no reported adverse event; Initial information received on 26-Feb-2024 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 4 months old male patient who was inadvertently given an expired dose of HIB (PRP/T) Vaccine [ACT-HIB] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Rotavirus Vaccine Live Reassort Oral 5v (Rotateq); Pneumococcal Vaccine Conj 20v (Crm197) (Prevnar 20); and Diphtheria Vaccine Toxoid, Hepatitis B Vaccine Rhbsag (Yeast), Pertussis Vaccine Acellular 3-Component, Polio Vaccine Inact 3v (Vero), Tetanus Vaccine Toxoid (Pediarix); all for Immunisation.  On 26-Feb-2024, the patient had inadvertently received 0.5 ml (dose: 2) of suspect HIB (PRP/T) Vaccine (Powder and solvent for solution for injection) (lot UJ834AA; expiration date: 23-Feb-2024; strength not reported) via intramuscular route in the left thigh for immunization with no reported adverse event (expired product administered) (latency: same day).  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.33
Sex: F
Vaccine: HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: an expired dose of ACTHIB was administered to a patient with no reported adverse event; Initial information received on 26-Feb-2024 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 16 months old female patient who received an expired dose of HIB (PRP/T) VACCINE [ACT-HIB] was administered to a patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 15V (CRM197) (VAXNEUVANCE) for Prophylactic vaccination.  On 26-Feb-2024, the patient received expired dose 0.5 ml, 1X total of suspect HIB (PRP/T) VACCINE, Powder and solvent for solution for injection (lot UJ834AA and expiry 23-02-24) (strength: unknown) (expired product administered, latency same day) via intramuscular route in the right thigh for prophylactic vaccination (immunization).  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain
Clinical narrative: still experiencing arm pain where the vaccine was injected; Initial information received on 27-Feb-2024 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 71 years old female patient who still was experiencing arm pain where the vaccine was injected after receiving INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 04-Jan-2024, the patient received 0.7 ml dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE via intramuscular route in the right deltoid for immunization (strength, form, batch and expiry date- unknown). Information on the batch number was requested.  On an unknown date the patient still was experiencing arm pain where the vaccine was injected (vaccination site pain) (unknown latency).  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event   At time of reporting, the outcome was Unknown for the event
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE/PQC; HCP called to report inadvertent administration of VARIVAX to multiple patients after a temperature excursion.; This spontaneous report has been received from a nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided.  On 21-FEB-2024, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (lot # X021284 with expiration date: 20-AUG-2025, dose, strength and route were unknown) inadvertently after a temperature excursion (product storage error) for prophylaxis. No additional adverse event/product quality complaint. Operator of Device: Health Professional.  Administered dose of varicella virus vaccine live (oka/merck) (VARIVAX) experienced the temperature excursion below 13.1 degree Celsius for 0 hours 18 minutes 0 seconds. No previous temperature excursions reported.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Asthenia, Chills, Fatigue, Feeling cold
Clinical narrative: About 18 hours after injection, I experienced: 1. soreness at the injection site, (sensitive to touch), 2. mild muscle/joint pain over most of my body, 3. definite tiredness/lack of strength, 4. occasional shivering/feeling cold, 5. slight nausea. There was no stomach upset, nor urge to vomit. The adverse symptoms lasted about 24 hours, and after that time, all the symptoms went away without any treatment other than a 200 mg ibuprofen (for the muscle/joint pain). I stayed home for the day and tried to relax, but could have driven myself for additional care if needed.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain, Myalgia, Nausea
Clinical narrative: About 18 hours after injection, I experienced: 1. soreness at the injection site, (sensitive to touch), 2. mild muscle/joint pain over most of my body, 3. definite tiredness/lack of strength, 4. occasional shivering/feeling cold, 5. slight nausea. There was no stomach upset, nor urge to vomit. The adverse symptoms lasted about 24 hours, and after that time, all the symptoms went away without any treatment other than a 200 mg ibuprofen (for the muscle/joint pain). I stayed home for the day and tried to relax, but could have driven myself for additional care if needed.
Age: 42.0
Sex: F
Vaccine: FLU4, HEP, HPV9, TDAP
Symptoms: Expired product administered, No adverse event
Clinical narrative: Hepatitis B Vaccine administered on 2/26/2024, patient did not exhibit any adverse effects from the vaccine. Once patient left facility, RN realized expiration date on vaccine stated 2/25/2024.
Age: 38.0
Sex: F
Vaccine: FLU4, HEP, HPV9
Symptoms: Expired product administered, No adverse event
Clinical narrative: Hepatitis B vaccine administered on 2/26/2024, patient did not exhibit any adverse effects from the vaccine. Once patient left facility, RN realized expiration date on vaccine states 2/25/2024.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Hospitalized with COVID
Age: 60.0
Sex: F
Vaccine: HEP
Symptoms: Arthralgia, Fatigue, Full blood count, Inflammation, Influenza like illness
Clinical narrative: Pt was administered the new hepatitis B booster shot (likely recombivax) on 1/30/24 after starting her new job as an acute dialysis nurse. She developed flu like symptoms that night with fatigue, joint pains as well as itching which began on the inside of her elbows. When she woke up in the middle of the night she noticed a rash in those areas. She describes it as "hot and itchy" but it doesn't hurt. It rapidly spread all over her body including her arms, breasts, abdomen, back, buttocks, thigh and legs. It spares her face/hands/groins. No rash in the armpits but does itch in that area as well. Her flulike sx resolved within 2 days but the rash continued to get worse. Denies fevers, chills, other infectious sx, joint pain. Itching somewhat relieved by castille soap, coconut oil and cold showers. Tried some old hydroxyzine she had at home which did not help (thinks its expired). Received a steroid shot at an urgent care yesterday which helped "about 25%" with the itching. She is UTD on zoster vaccines. Works as an acute dialysis nurse and reports her patients are "always itchy", but no known close contact with a scabies patient. Lives with her dog and reports he hasn't been itchy.  On exam, erythematous pruritic, papular rash with 1-2 mm papules and interspersed erythema in b/l cubital fossae, all over the torso including breasts, abdomen, back. Also over upper and lower extremities and buttocks. Inflamed appearance, slightly warm to the touch but non tender.
Age: 60.0
Sex: F
Vaccine: HEP
Symptoms: Metabolic function test, Pruritus, Rash, Rash papular, Rash pruritic
Clinical narrative: Pt was administered the new hepatitis B booster shot (likely recombivax) on 1/30/24 after starting her new job as an acute dialysis nurse. She developed flu like symptoms that night with fatigue, joint pains as well as itching which began on the inside of her elbows. When she woke up in the middle of the night she noticed a rash in those areas. She describes it as "hot and itchy" but it doesn't hurt. It rapidly spread all over her body including her arms, breasts, abdomen, back, buttocks, thigh and legs. It spares her face/hands/groins. No rash in the armpits but does itch in that area as well. Her flulike sx resolved within 2 days but the rash continued to get worse. Denies fevers, chills, other infectious sx, joint pain. Itching somewhat relieved by castille soap, coconut oil and cold showers. Tried some old hydroxyzine she had at home which did not help (thinks its expired). Received a steroid shot at an urgent care yesterday which helped "about 25%" with the itching. She is UTD on zoster vaccines. Works as an acute dialysis nurse and reports her patients are "always itchy", but no known close contact with a scabies patient. Lives with her dog and reports he hasn't been itchy.  On exam, erythematous pruritic, papular rash with 1-2 mm papules and interspersed erythema in b/l cubital fossae, all over the torso including breasts, abdomen, back. Also over upper and lower extremities and buttocks. Inflamed appearance, slightly warm to the touch but non tender.
Age: 60.0
Sex: F
Vaccine: HEP
Symptoms: Skin warm
Clinical narrative: Pt was administered the new hepatitis B booster shot (likely recombivax) on 1/30/24 after starting her new job as an acute dialysis nurse. She developed flu like symptoms that night with fatigue, joint pains as well as itching which began on the inside of her elbows. When she woke up in the middle of the night she noticed a rash in those areas. She describes it as "hot and itchy" but it doesn't hurt. It rapidly spread all over her body including her arms, breasts, abdomen, back, buttocks, thigh and legs. It spares her face/hands/groins. No rash in the armpits but does itch in that area as well. Her flulike sx resolved within 2 days but the rash continued to get worse. Denies fevers, chills, other infectious sx, joint pain. Itching somewhat relieved by castille soap, coconut oil and cold showers. Tried some old hydroxyzine she had at home which did not help (thinks its expired). Received a steroid shot at an urgent care yesterday which helped "about 25%" with the itching. She is UTD on zoster vaccines. Works as an acute dialysis nurse and reports her patients are "always itchy", but no known close contact with a scabies patient. Lives with her dog and reports he hasn't been itchy.  On exam, erythematous pruritic, papular rash with 1-2 mm papules and interspersed erythema in b/l cubital fossae, all over the torso including breasts, abdomen, back. Also over upper and lower extremities and buttocks. Inflamed appearance, slightly warm to the touch but non tender.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalized with COVID
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Feeling abnormal, Feeling hot, Insomnia, Neck pain
Clinical narrative: Right arm had shingles vaccine on Thursday. Woke up feeling off on Friday; body aches, pain, localized redness, heat and swelling. Now pain has been progressing over arm and to the base of her neck. Can barely sleep. Taking Aleve.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pain in extremity, Swelling
Clinical narrative: Right arm had shingles vaccine on Thursday. Woke up feeling off on Friday; body aches, pain, localized redness, heat and swelling. Now pain has been progressing over arm and to the base of her neck. Can barely sleep. Taking Aleve.
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 6m-4 years varriation was given and client was 5 years 14 days at time of vaccination
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: it was deactivated 9/11/23 we gave it 9/12/23. State board of health said we have to fill this out
Age: 8.0
Sex: F
Vaccine: DTPPVHBHPB
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse reaction reported.
Age: 7.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient given Kinrix (Dtap-IPV) instead of Tap since she is 7 yrs old. She has experienced no symptoms and is doing well.
Age: 83.0
Sex: F
Vaccine: PNC20
Symptoms: Alopecia
Clinical narrative: Patient states her hair  has started to fall out shortly.
Age: 7.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Patient was given Kinrix (DTap-IPV) which is for ages 4-6yrs. Received this at age 7yrs 2mo. She should have received Tdap instead. Patient has no symptoms, doing well according  to parent.
Age: 68.0
Sex: M
Vaccine: RSV
Symptoms: Rash
Clinical narrative: Rash to back, stomach, and right side of neck (per PCP's 12/8/23 note).
Age: 27.0
Sex: F
Vaccine: YF
Symptoms: Mouth swelling, Paraesthesia oral
Clinical narrative: Patient called Immunization/Travel Clinic after receiving YF vaccination today. Call transferred to RN, patient identity verified x2. Patient reports diffuse red rash, hives, that has spread to torso, back, neck and face. RN asked about the following symptoms; patient reports no difficulty breathing, no n/v, but positive for mouth feeling tingly and swelling likely. RN advised patient to take diphenhydramine if available and no difficulty swallowing, and seek urgent/emergent medication attention as symptoms concerning for severe allergic reaction. Patient verbalized understanding and in agreement with plan, no additional questions/concerns at this time. RN to follow up.  1645 -  RN called patient to follow up. Patient confirmed she was able to get to an EDTC and is currently receiving medical care. RN let patient know she would also follow up tomorrow, patient in agreement with plan.
Sex: F
Vaccine: MENB
Symptoms: Hypophagia, Infant irritability, Product administered to patient of inappropriate age
Clinical narrative: Bexsero vaccine was given to a 2 week old infant instead of the Hepatitis B vaccine. The parent was informed by the doctor and instructed on what to watch for and to call back if any concerns. Parent reported some fussiness and eating less than the day before, but otherwise baby was doing okay.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Perioral dermatitis, Pruritus, Rash, Urticaria
Clinical narrative: Small hive on inside right lower arm first.  A couple of days later it became larger.  Hives appeared on on upper right arm also. On 2/23 hives appeared on my stomach right side.  On 2/24 hives also appeared on my left lower back.  A small bump appeared under my right eyelid and some small ones around my lips also. Hives on body were very itchy and hurt.  Took Benadryl for a couple of days but didn't help. Went to doctor on 2/27 and she prescribed Hydrocorisone cream, Cetirize HCL 100MG, and Methylprednisolone.  Started medicine on 2/28 and itching became better.  Hives on eyelid and around mouth went away.  Still have hives on my arm, stomach, and back.  Hopefully this will go away when medication is finished.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Adjustment disorder with depressed mood, Anaemia of pregnancy, COVID-19, Hypertension, Maternal exposure before pregnancy
Clinical narrative: Discharge date and time: 2/26/2024 11:12 PM  Admitting Provider: CNM   Discharge Provider: CNM  Admission Diagnoses:   Diagnosis ? Obesity, Class I, BMI 30-34.9 ? Grand multiparity ? Adjustment disorder with depressed mood ? Chronic hypertension affecting pregnancy ? COVID-19 affecting pregnancy in third trimester ? Anemia during pregnancy in third trimester ? 37 weeks gestation of pregnancy ? Encounter for induction of labor  Discharge Diagnoses:   Diagnosis ? Obesity, Class I, BMI 30-34.9 ? Grand multiparity ? Adjustment disorder with depressed mood ? Chronic hypertension affecting pregnancy ? COVID-19 affecting pregnancy in third trimester ? Anemia during pregnancy in third trimester ? 37 weeks gestation of pregnancy ? Encounter for induction of labor  Prenatal Procedures: Ultrasound # 9    Intrapartum Procedures: Undelivered   SUBJECTIVE: Patient is 30yo G8P4216 who was kept for IOL for CHTN after being seen on L&D the past few days for utx. She was started on Pitocin with no cervical change achieved with 14 miu/min. Discussed that she could continue to stay and be induced or come back on 2/29/2024 at which time she will be off Covid precautions and her GBS status should be resulted.  ASSESSMENT:  30 YO G8P4216 at 37w4d Labor status:  not in labor FHR status:  Category 1 Membrane status:  intact GBS unknown Covid positive in pregnancy CHTN  PLAN: Will return to L&D on Thursday 2/29/2024 for IOL for CHTN Discharge home with routine instructions.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Multiparous, Obesity
Clinical narrative: Discharge date and time: 2/26/2024 11:12 PM  Admitting Provider: CNM   Discharge Provider: CNM  Admission Diagnoses:   Diagnosis ? Obesity, Class I, BMI 30-34.9 ? Grand multiparity ? Adjustment disorder with depressed mood ? Chronic hypertension affecting pregnancy ? COVID-19 affecting pregnancy in third trimester ? Anemia during pregnancy in third trimester ? 37 weeks gestation of pregnancy ? Encounter for induction of labor  Discharge Diagnoses:   Diagnosis ? Obesity, Class I, BMI 30-34.9 ? Grand multiparity ? Adjustment disorder with depressed mood ? Chronic hypertension affecting pregnancy ? COVID-19 affecting pregnancy in third trimester ? Anemia during pregnancy in third trimester ? 37 weeks gestation of pregnancy ? Encounter for induction of labor  Prenatal Procedures: Ultrasound # 9    Intrapartum Procedures: Undelivered   SUBJECTIVE: Patient is 30yo G8P4216 who was kept for IOL for CHTN after being seen on L&D the past few days for utx. She was started on Pitocin with no cervical change achieved with 14 miu/min. Discussed that she could continue to stay and be induced or come back on 2/29/2024 at which time she will be off Covid precautions and her GBS status should be resulted.  ASSESSMENT:  30 YO G8P4216 at 37w4d Labor status:  not in labor FHR status:  Category 1 Membrane status:  intact GBS unknown Covid positive in pregnancy CHTN  PLAN: Will return to L&D on Thursday 2/29/2024 for IOL for CHTN Discharge home with routine instructions.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tooth resorption
Clinical narrative: TOOTH RESORPTION IN 3 TEETH
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory distress syndrome, Acute respiratory failure, Atrial fibrillation, COVID-19, Cardiac failure acute
Clinical narrative: Admit date: 2/15/2024  Discharge date: 02/28/24   Admitting Physician: MD   Attending Physician at the Time of Discharge: MD  Primary Care Physician: NP Reason for Admission: dyspnea  Hospital Course:   75 year old male who presented to the ED for dyspnea. He has past medical history of COPD, CHF, atrial fibrillation, hypothyroidism and hypertension. He tested positive for COVID-19 this morning and arrived via EMS in acute respiratory distress. He was given duonebs, epinephrine and solumedrol in the ED and placed on BiPAP. CCU was consulted and the decision was made for intubation due to extreme hypercapnia and respiratory distress.  These issues were addressed while in the hospital.  1.Acute on chronic hypoxic, hypercapnic respiratory failure :  He was intubated and then was placed on high-flow oxygen. Continue to wean. Add Mucinex  2. Sepsis related to Aspiration pneumonia, completed treatment with 7 days' course of Unasyn  3.Acute on chronic systolic heart failure-   - continue with oral Lasix 20 mg.  Continue carvedilol 2 times a day  4.Chronic obstructive pulmonary disease, chronic respiratory failure  - Symbicort Spiriva, DuoNebs as needed, steroids as above  5. COVID-19:  Treated with steroids and remdesivir  6.Permanent atrial fibrillation -   - resume warfarin PTD   - Continue to monitor on tele  7.Pulmonary hypertension - likely due to chronic obstructive pulmonary disease and CHF.   8. Severe malnutrition:  Nutrition was consulted  9. Gross hematuria related to warfarin anticoagulation.  Treated with reversal agent and continuous irrigation. Discharged to SNF
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Chronic respiratory failure, Dyspnoea, Endotracheal intubation, Haematuria
Clinical narrative: Admit date: 2/15/2024  Discharge date: 02/28/24   Admitting Physician: MD   Attending Physician at the Time of Discharge: MD  Primary Care Physician: NP Reason for Admission: dyspnea  Hospital Course:   75 year old male who presented to the ED for dyspnea. He has past medical history of COPD, CHF, atrial fibrillation, hypothyroidism and hypertension. He tested positive for COVID-19 this morning and arrived via EMS in acute respiratory distress. He was given duonebs, epinephrine and solumedrol in the ED and placed on BiPAP. CCU was consulted and the decision was made for intubation due to extreme hypercapnia and respiratory distress.  These issues were addressed while in the hospital.  1.Acute on chronic hypoxic, hypercapnic respiratory failure :  He was intubated and then was placed on high-flow oxygen. Continue to wean. Add Mucinex  2. Sepsis related to Aspiration pneumonia, completed treatment with 7 days' course of Unasyn  3.Acute on chronic systolic heart failure-   - continue with oral Lasix 20 mg.  Continue carvedilol 2 times a day  4.Chronic obstructive pulmonary disease, chronic respiratory failure  - Symbicort Spiriva, DuoNebs as needed, steroids as above  5. COVID-19:  Treated with steroids and remdesivir  6.Permanent atrial fibrillation -   - resume warfarin PTD   - Continue to monitor on tele  7.Pulmonary hypertension - likely due to chronic obstructive pulmonary disease and CHF.   8. Severe malnutrition:  Nutrition was consulted  9. Gross hematuria related to warfarin anticoagulation.  Treated with reversal agent and continuous irrigation. Discharged to SNF
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Hypercapnia, Left ventricular failure, Malnutrition, Pneumonia aspiration, Positive airway pressure therapy
Clinical narrative: Admit date: 2/15/2024  Discharge date: 02/28/24   Admitting Physician: MD   Attending Physician at the Time of Discharge: MD  Primary Care Physician: NP Reason for Admission: dyspnea  Hospital Course:   75 year old male who presented to the ED for dyspnea. He has past medical history of COPD, CHF, atrial fibrillation, hypothyroidism and hypertension. He tested positive for COVID-19 this morning and arrived via EMS in acute respiratory distress. He was given duonebs, epinephrine and solumedrol in the ED and placed on BiPAP. CCU was consulted and the decision was made for intubation due to extreme hypercapnia and respiratory distress.  These issues were addressed while in the hospital.  1.Acute on chronic hypoxic, hypercapnic respiratory failure :  He was intubated and then was placed on high-flow oxygen. Continue to wean. Add Mucinex  2. Sepsis related to Aspiration pneumonia, completed treatment with 7 days' course of Unasyn  3.Acute on chronic systolic heart failure-   - continue with oral Lasix 20 mg.  Continue carvedilol 2 times a day  4.Chronic obstructive pulmonary disease, chronic respiratory failure  - Symbicort Spiriva, DuoNebs as needed, steroids as above  5. COVID-19:  Treated with steroids and remdesivir  6.Permanent atrial fibrillation -   - resume warfarin PTD   - Continue to monitor on tele  7.Pulmonary hypertension - likely due to chronic obstructive pulmonary disease and CHF.   8. Severe malnutrition:  Nutrition was consulted  9. Gross hematuria related to warfarin anticoagulation.  Treated with reversal agent and continuous irrigation. Discharged to SNF
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary hypertension, Respiratory distress, Respiratory failure, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Admit date: 2/15/2024  Discharge date: 02/28/24   Admitting Physician: MD   Attending Physician at the Time of Discharge: MD  Primary Care Physician: NP Reason for Admission: dyspnea  Hospital Course:   75 year old male who presented to the ED for dyspnea. He has past medical history of COPD, CHF, atrial fibrillation, hypothyroidism and hypertension. He tested positive for COVID-19 this morning and arrived via EMS in acute respiratory distress. He was given duonebs, epinephrine and solumedrol in the ED and placed on BiPAP. CCU was consulted and the decision was made for intubation due to extreme hypercapnia and respiratory distress.  These issues were addressed while in the hospital.  1.Acute on chronic hypoxic, hypercapnic respiratory failure :  He was intubated and then was placed on high-flow oxygen. Continue to wean. Add Mucinex  2. Sepsis related to Aspiration pneumonia, completed treatment with 7 days' course of Unasyn  3.Acute on chronic systolic heart failure-   - continue with oral Lasix 20 mg.  Continue carvedilol 2 times a day  4.Chronic obstructive pulmonary disease, chronic respiratory failure  - Symbicort Spiriva, DuoNebs as needed, steroids as above  5. COVID-19:  Treated with steroids and remdesivir  6.Permanent atrial fibrillation -   - resume warfarin PTD   - Continue to monitor on tele  7.Pulmonary hypertension - likely due to chronic obstructive pulmonary disease and CHF.   8. Severe malnutrition:  Nutrition was consulted  9. Gross hematuria related to warfarin anticoagulation.  Treated with reversal agent and continuous irrigation. Discharged to SNF
Age: 23.0
Sex: M
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: The patient received two doses of the influenza vaccine at different sites. The first dose was administered at the immunization clinic and the second dose was received later at the mass flu line.
Age: 0.33
Sex: F
Vaccine: DTPPVHBHPB, PNC20, RV5
Symptoms: Crying, Erythema, Pain, Skin discolouration
Clinical narrative: Patient had vaccines on 1/25/2024:Vaxelis.PCV20 , Rota: and parent reports:    Funny episode Sitting on dads lap. Started to cry loudly. R foot seemed purplish as did her legs.  Really painful cry as if foot was broken Seemed like face turned purple so she was crying   too much. Site was not    Dad Bath  Put on cream Creaming as if in pain Legs turned really read L leg seemed black and blue, duration 10-20 minutes. When crying just bottom half seemed beat red. Face red from crying. Face was not  abnormally red nor was purple.  Fine to red then to purple then very quickly was fine.  Correlated  with the crying.  Foot looked broken, per Mom like bruising.  No swelling.
Age: 4.0
Sex: F
Vaccine: MMRV
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reaction. Expired vaccine given. Manufacture called. Vaccine no viable. Patient to be contacted for revaccination. Patient had no adverse reactions or symptoms.
Age: 63.0
Sex: M
Vaccine: COVID19, RSV, COVID19-2, RSV
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Injection site swelling, Pain
Clinical narrative: RED/SWELLING/INFLAMMATION/PAIN STARTING AT INJECTION SITE AND SPREADING DOWN ARM
Age: 63.0
Sex: M
Vaccine: COVID19, RSV, COVID19-2, RSV
Symptoms: Rash
Clinical narrative: RED/SWELLING/INFLAMMATION/PAIN STARTING AT INJECTION SITE AND SPREADING DOWN ARM
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: No adverse event, Product preparation error
Clinical narrative: No adverse event. The medical assistant mixed the powder portion of the Shingrix with Merck Sterile water diluent instead of the diluent that comes with and is intended for the Shingrix.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Extra dose administered
Clinical narrative: Duplicate vaccine given
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Nurse transporting vaccine did not check beyond use date before packing vaccines for clinic. Vaccine was administered a day past beyond use date of 02/28/2024 at 09:00 am (administered 02/29/2024 at 2:30 pm). No adverse reactions or symptoms noted; patient tolerated 15 min wait time after vaccination fine and no symptoms were reported by patient. Error not noted until close of clinic. Vaccines discarded once aware of error and Head of Immunizations Department notified.
Age: 27.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The vaccine that was administered to the patient had a beyond use date of 02/28/2024 @ 0900, the vaccine was administered on 02/29/2024 at 1430.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: We are a mobile clinic operating within our county. The nurse who transported the vaccines to our location for the day did not review the Beyond Use Date (BUD) prior to packing vaccines and prior to our team administering the vaccines. The nurse who transported and monitored the vaccine did not successfully check the date and I as the vaccinator was unaware of the BUD at the time.  The BUD was 02/28/2024 @ 0900 and I administered the vaccine 1 day later at 2:30pm. This error was not discovered til close of clinic when I transported the vaccine back and notified the head of the immunizations department at our facility.  No symptoms or signs reported by patient in their 15 minute wait time, no adverse reaction to the vaccine. The adverse event was solely related to the vaccine being outside of the BUD 10 week span by 1 day.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: Patient given undiluted COVID-19 vaccine for 6 mo-4 year (dilution and preparation of the multi-dose vial did not occur). The patient received an equivalent of 3 doses of the vaccine.
Age: 90.0
Sex: M
Vaccine: RSV
Symptoms: Diarrhoea, Dizziness, Injection site bruising, Injection site swelling
Clinical narrative: Patient experience dizziness within a couple of hours of the vaccination.  Patient experience significant swelling and bruising at the injection site. Patient experienced diarrhea for three days following the vaccination.
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The vaccine that the patient was administered had a beyond use date of 02/28/2024 @ 0900, the vaccine was administered to the patient on 02/29/2024 at 1445.
Age: 69.0
Sex: M
Vaccine: FLU4, PNC20
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient had no adverse events.  This was a 2nd dose of influenza vaccine he was given in error.  He was given a dose of High Dose influenza on 11/20/23
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: Vaccine was frozen instead of refrigerated.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: We are a mobile clinic operating within our county. The nurse who transported the vaccines to our location for the day did not review the Beyond Use Date (BUD) prior to packing vaccines and prior to our team administering the vaccines. The nurse who transported and monitored the vaccine did not successfully check the date and I as the vaccinator was unaware of the BUD at the time.  The BUD was 02/28/2024 @ 0900 and I administered the vaccine 1 day later at 2:45pm. This error was not discovered til close of clinic when I transported the vaccine back and notified the head of the immunizations department at our facility.  No symptoms or signs reported by patient in their 15 minute wait time, no adverse reaction to the vaccine. The adverse event was solely related to the vaccine being outside of the BUD 10 week span by 1 day.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Nurse transporting vaccine did not check beyond use date before packing vaccines for clinic. Vaccine was administered a day past beyond use date of 02/28/2024 at 09:00 am (administered 02/29/2024 at 2:30 pm). No adverse reactions or symptoms noted or reported by patient; patient tolerated 15 min wait time after vaccination fine. Error not noted until close of clinic. Vaccines discarded once aware of error and Head of Immunizations Department notified.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Shoulder injury related to vaccine administration
Clinical narrative: Patient was given the injection then was seen a few days later in urgent care and it was determined that they had a shoulder injury due to vaccine administration
Age: 54.0
Sex: F
Vaccine: RSV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: SWELLING, WARMTH, REDNESS, AND ITCHING TO ADMINISTRATION SITE. NO MTREATMENT RENDERED
Age: 73.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Arthralgia, Chest discomfort, Chills, Hyperhidrosis, Nausea
Clinical narrative: Patient woke up in middle of night after receiving vaccines at 15:20 and had neck, shoulder, jaw pain, nausea, chills/sweating, chest tightness and presycnope.  she called RN advice next am and by 9:40 am 10/20 reported resolution of symptoms
Age: 73.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Neck pain, Pain in jaw, Presyncope
Clinical narrative: Patient woke up in middle of night after receiving vaccines at 15:20 and had neck, shoulder, jaw pain, nausea, chills/sweating, chest tightness and presycnope.  she called RN advice next am and by 9:40 am 10/20 reported resolution of symptoms
Age: 41.0
Sex: F
Vaccine: COVID19-2, FLU4, HEP, MMR, TDAP
Symptoms: Chest discomfort, Chest pain, Rash
Clinical narrative: n Wednesday 02/28/24 approximately 12:00PM. Client, age 41, arrives to clinic and requests adult vaccines with Rx script that was additionally presented from Dr., MD. When patient was first encountered by, LVN, VIS information needed about the vaccines being administered were provided. Patient stated being nervous about receiving Covid-19 vaccine since she had never received the vaccine before. Nurse, LVN provided education about Moderna vaccine and client verbalized understanding and gave consent to vaccines. Prior to administering vaccines, LVN observed signs of anxiousness and nervousness. At approximately 12:08PM, vaccines were administered. At 12:10PM, patient left vaccination room after receiving vaccines. At 12:14PM, patient reported to front desk with signs of chest discomfort and ambulated independently and was seated back into vaccination room with no assistance needed. Additionally, at 12:15PM, EMS was activated. LVN asked patient what symptoms she was experiencing, and patient described her heart feeling heavy. LVN noted a rash on her chest and neck. LVN assessed no signs of difficulty breathing, or shortness of breath, or difficulty swallowing. At 12:26PM, RN and RN arrived to vaccination room to assist with emergency. Both nurses noted rash on chest/neck and signs of anxiousness. A&O x4 was also noted by both nurses. No swelling was noted on patients face and did not have difficulty breathing and/or swallowing. Reported also that chest pain 10/10 has resolved within 10 seconds after experiencing chest pain and was no longer in any pain.  Patient denies having diabetes and reported not having anything to eat yet. Patient reported having an allergic reaction to Morphine in the past and had a similar reaction of rash on her chest. No other symptom were reported to nurses. At, 12:29PM Fire Department arrived at took over care of patient. Patient received Benadryl IM on Right Arm at 12:33PM. Vitals taken by EMS were noted being within normal limits. At 12:35PM, patient declines to go to hospital and is given precautions. Patient was educated on safety of driving due to drowsiness from Benadryl and was told to call someone to pick her up. 12:39PM, Paramedics left facility. Patient stayed until being able to contact family friend to pick her up and was offered a juice and a granola bar. Patient remained seated during the rest of the time. At 12:50PM, family friend arrived, and patient left the building. Patient reported no symptoms and ambulated independently as she left the building with family friend.
Age: 43.0
Sex: F
Vaccine: HEP, HEPA, MNQ
Symptoms: Injection site rash, Pain in extremity
Clinical narrative: Patient has rash on RIGHT ARM near deltoid region, starting on Wednesday, after receiving Menquadfi (RDIM), Havrix (LDIM), and Heplisav (LDIM) on Monday 02/26/24. Declines itching/SOB or any other symptoms aside from sore arm. Declines any other rash on any other part of body (her rash is localized Right deltoid). Has not taken any medication for symptom relief. States rash has been improving since Wednesday. Patient declines any reaction to vaccines in the past and declines any known allergies aside from pollen and cats.
Age: 22.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Chills, Fatigue, Headache, Injection site erythema, Injection site induration
Clinical narrative: After a week of receiving the vaccines, the injection site is still red, warm to touch, and the skin is very hard around injection site. Severe soreness, weak mobility of arm, severe itchiness. Headaches, severe nausea, fatigue, chills and body aches.
Age: 22.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Injection site warmth, Muscular weakness, Nausea, Pain, Pain in extremity
Clinical narrative: After a week of receiving the vaccines, the injection site is still red, warm to touch, and the skin is very hard around injection site. Severe soreness, weak mobility of arm, severe itchiness. Headaches, severe nausea, fatigue, chills and body aches.
Age: 22.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Pruritus
Clinical narrative: After a week of receiving the vaccines, the injection site is still red, warm to touch, and the skin is very hard around injection site. Severe soreness, weak mobility of arm, severe itchiness. Headaches, severe nausea, fatigue, chills and body aches.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site reaction, Myalgia, Pain, Pain in extremity, Pyrexia
Clinical narrative: Pt reports fever of 101 F for 24 hours, after vaccine administration, in addition to muscle and body aches a. Pt also reports welt at injection site for 2-3 weeks in addition to sore arm for the same amount of time.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Urticaria
Clinical narrative: Pt reports fever of 101 F for 24 hours, after vaccine administration, in addition to muscle and body aches a. Pt also reports welt at injection site for 2-3 weeks in addition to sore arm for the same amount of time.
Age: 68.0
Sex: M
Vaccine: FLU4
Symptoms: Cardiac disorder, Death
Clinical narrative: Patient found in home deceased 2/24/24 suspect cardiac event
Age: 65.0
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: Vaccine was frozen instead of refrigerated.
Age: 2.0
Sex: F
Vaccine: DTAPHEPBIP, HEPA, PNC20
Symptoms: Gait disturbance, Knee deformity, Toe walking
Clinical narrative: Patient was refusing to walk and then started walking on her tip toes. Patient then started showing signs of knocked knees and was kicking her feet out to walk.
Age: 71.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Back pain, Blood creatine increased, Blood creatine phosphokinase, Blood lactic acid
Clinical narrative: Patient had shingrix vaccine on 1/31/24, then on 2/3/24 he started developing body aches, fatigue, weakness, myalgias in legs, neck & back pain, went to ER on 2/4/24 to be evaluated had following labs drawn: CMP, CBC, Creatine kinase, lactate venous, Influenza & covid test. On 2/9/24 he followed up with our office he was improving at that time. pt called office on 2/27/24-he developed a rash on his arm in the same site shingrix vaccine was given on left arm, left arm, pain, painful muscles/myalgias, pt was seen in office on 3/1/24-labs were drawn today for  CBC, CMP, sed Rate, Creatine kinase total results are pending.